Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer

医学 腋窝 乳腺癌 外科 腋窝淋巴结清扫术 阶段(地层学) 前哨淋巴结 放射治疗 临床终点 活检 随机对照试验 哨兵节点 癌症 放射科 内科学 古生物学 生物
作者
Ákos Sávolt,Gábor Péley,Csaba Polgár,Nóra Udvarhelyi,Gábor Rubovszky,Eszter Márta Kovács,Balázs Győrffy,Miklós Kásler,Zoltán Mátrai
出处
期刊:Ejso [Elsevier BV]
卷期号:43 (4): 672-679 被引量:352
标识
DOI:10.1016/j.ejso.2016.12.011
摘要

The National Institute of Oncology, Budapest conducted a single centre randomized clinical study. The OTOASOR (Optimal Treatment Of the Axilla - Surgery Or Radiotherapy) trial compares completion of axillary lymph node dissection (cALND) to regional nodal irradiation (RNI) in patients with sentinel lymph node metastasis (pN1sn) in stage I-II breast cancer.Patients with primary invasive breast cancer (cN0 and cT ≤ 3 cm) were randomized before surgery for cALND (standard treatment) or RNI (investigational treatment). Sentinel lymph nodes (SN) were investigated with serial sectioning at 0.5 mm levels by hematoxylin-eosin staining. Investigational treatment arm patients received 50 Gy RNI instead of cALND. Adjuvant treatment and follow up were performed according to the actual guidelines. Between August 2002 and June 2009, 1054 patients were randomized for cALND and 1052 patients for RNI. SN was evaluated in 2073 patients and was positive in 526 patients (25.4%). 474 cases were evaluable (244 in the cALND and 230 in the RNI arm), and in the cALND group 94 of 244 patients (38.5%) who underwent completion axillary surgery has additional positive nodes. The two arms were well balanced according to the majority of main prognostic factors. Primary endpoint was axillary recurrence and secondary endpoints were overall survival (OS) and disease-free survival (DFS).Mean follow-up was 97 months (Q1-Q3: 80-120). Axillary recurrence was 2.0% in cALND arm vs. 1.7% in RNI arm (p = 1.00). OS at 8 years was 77.9% vs. 84.8% (p = 0.060), and DFS was 72.1% in cALND arm and 77.4% after RNI (p = 0.51). The results show that RNI is statistically not inferior to cALND treatment.The long term follow-up results of this prospective-randomized trial suggest that RNI without cALND does not increase the risk of axillary failure in selected patients with early-stage invasive breast cancer (cT ≤ 3 cm, cN0) and pN1(sn). Axillary radiotherapy should be an alternative treatment for selected patients with sentinel lymph node metastases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FYY发布了新的文献求助10
刚刚
刚刚
不错吧完成签到,获得积分10
刚刚
dd发布了新的文献求助10
刚刚
lan__完成签到,获得积分10
刚刚
seashell发布了新的文献求助10
1秒前
ttchen的应助被涉江采纳,获得10
1秒前
文献发布了新的文献求助10
1秒前
Hello的应助被壮壮的小胖子采纳,获得30
1秒前
迷人的Jack发布了新的文献求助10
2秒前
拉长的觅儿完成签到,获得积分10
2秒前
星辰大海的应助被luo采纳,获得10
2秒前
学习发布了新的文献求助10
2秒前
wjwless发布了新的文献求助10
2秒前
bioseraph完成签到,获得积分10
2秒前
星辰大海的应助被dwhfuehfuh采纳,获得10
3秒前
传奇3的应助被阿果采纳,获得10
3秒前
3秒前
cwtt完成签到 ,获得积分10
3秒前
啊生存手册完成签到 ,获得积分10
3秒前
阿菅完成签到 ,获得积分10
3秒前
3秒前
剑兰先生完成签到,获得积分10
4秒前
Running完成签到 ,获得积分10
4秒前
zhl发布了新的文献求助10
4秒前
5秒前
5秒前
5秒前
小懿发布了新的文献求助10
5秒前
鳗鱼丹秋完成签到,获得积分10
5秒前
枳酒发布了新的文献求助10
5秒前
5秒前
6秒前
谢耳朵发布了新的文献求助10
6秒前
谢耳朵发布了新的文献求助10
6秒前
6秒前
图图发布了新的文献求助100
6秒前
月见草完成签到 ,获得积分10
6秒前
wzppp发布了新的文献求助10
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155816
求助须知:如何正确求助?哪些是违规求助? 9552109
关于积分的说明 21708107
捐赠科研通 7744978
什么是DOI,文献DOI怎么找? 3426225
关于科研通互助平台的介绍 2551237
邀请新用户注册赠送积分活动 2469958